Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Wall Street Analysts Think Lilly (LLY) Is a Good Investment: Is It?
Wall Street Analysts Think Lilly (LLY) Is a Good Investment: Is It?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Here's Why Investors Should Avoid Air Lease Stock for Now
Here's Why Investors Should Avoid Air Lease Stock for Now

Air Lease AL is mired in significant challenges stemming from increased expenses and weak liquidity. Geopolitical uncertainty is also hurting the company’s prospects, making it an unattractive

Alcoa's Aluminum Segment Gains Momentum: Can it Sustain?
Alcoa's Aluminum Segment Gains Momentum: Can it Sustain?

Alcoa Corporation’s AA Aluminum segment is benefiting from strong demand in the electrical and packaging end markets in North America and Europe and continued progress on the San Ciprián, Spain

LLY Up 28% in 3 Months: Is it the Right Time to Invest in the Stock?
LLY Up 28% in 3 Months: Is it the Right Time to Invest in the Stock?

Eli Lilly and Company’s LLY stock has risen 28% in the past three months. With exceptional growth from its GLP-1 drugs, Mounjaro and Zepbound, Lilly has become the first and only drugmaker to hit a

Qualcomm Witnesses Just 8.2% Growth in Past Year: Reason to Worry?
Qualcomm Witnesses Just 8.2% Growth in Past Year: Reason to Worry?

Qualcomm Incorporated QCOM shares have gained a modest 8.2% over the past year compared with the industry’s growth of 35.7%. Although it has outperformed peers like Hewlett Packard Enterprise

Jabil Rises 58% in a Year on Secular Growth Drivers: Worth Buying Now?: https://staticx-tuner.zacks.com/images/articles/main/95/133950.webp
Jabil Rises 58% in a Year on Secular Growth Drivers: Worth Buying Now?

Jabil, Inc. JBL has soared 58.1% over the past year compared with the industry’s growth of 97.6%. It has outperformed peers like Flex Ltd. FLEX but lagged Celestica Inc. CLS over this period. While

Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026
Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026

Shares of Ironwood Pharmaceuticals IRWD were up 26.7% on Jan. 2 after the company announced upbeat revenue guidance for 2026. The company maintained its revenue guidance for full-year 2025, which it

Lumentum Trades Near 52-Week High: Is the LITE Stock Still a Buy?
Lumentum Trades Near 52-Week High: Is the LITE Stock Still a Buy?

Lumentum Holdings LITE shares closed at $386.11 on Friday, which is close to the 52-week high of $401.60 it hit on Dec. 24, 2025. LITE shares have jumped a whopping 326.9% in a year, outperforming

OPFI Stock Jumps 36% in a Year: Should You Hold or Fold Now?
OPFI Stock Jumps 36% in a Year: Should You Hold or Fold Now?

OppFi Inc. OPFI shares have risen 36.3% over the past year. It has outpaced the 7.9% decline of its industry and 18.4% growth of the Zacks S&P 500 Composite.

1-Year Share Price Performance

 

Image

3 Reasons Why Growth Investors Shouldn't Overlook REV Group (REVG)
3 Reasons Why Growth Investors Shouldn't Overlook REV Group (REVG)

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't

3 Reasons Growth Investors Will Love Vertiv (VRT)
3 Reasons Growth Investors Will Love Vertiv (VRT)

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Here is Why Growth Investors Should Buy FMC Technologies (FTI) Now
Here is Why Growth Investors Should Buy FMC Technologies (FTI) Now

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Is APi (APG) a Solid Growth Stock? 3 Reasons to Think "Yes"
Is APi (APG) a Solid Growth Stock? 3 Reasons to Think "Yes"

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Is Argan (AGX) a Solid Growth Stock? 3 Reasons to Think "Yes"
Is Argan (AGX) a Solid Growth Stock? 3 Reasons to Think "Yes"

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Vertiv Rallies 31% in a Year: Should You Buy the Stock?
Vertiv Rallies 31% in a Year: Should You Buy the Stock?

Vertiv VRT shares have gained 31% in the trailing 12-month period, outperforming the broader Zacks Computer and Technology sector’s increase of 22.6%. The Zacks Computers - IT Services industry

Hennes & Mauritz (HNNMY) Upgraded to Buy: What Does It Mean for the Stock?
Hennes & Mauritz (HNNMY) Upgraded to Buy: What Does It Mean for the Stock?

Hennes & Mauritz AB (HNNMY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings

Kezar Life Sciences (KZR) Upgraded to Buy: Here's What You Should Know
Kezar Life Sciences (KZR) Upgraded to Buy: Here's What You Should Know

Investors might want to bet on Kezar Life Sciences, Inc. (KZR), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates

S&P Global (SPGI) Upgraded to Buy: Here's Why
S&P Global (SPGI) Upgraded to Buy: Here's Why

S&P Global (SPGI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock

Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know
Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know

Investors might want to bet on Vivos Therapeutics, Inc. (VVOS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces

MP Materials Trades at Premium Value: Here's How to Play the Stock: https://staticx-tuner.zacks.com/images/articles/main/2e/128521.webp
MP Materials Trades at Premium Value: Here's How to Play the Stock

MP Materials MP is trading at a forward 12-month price/sales multiple of 22.93X, a significant premium to the industry’s 1.44X. It has a Value Score of F, which suggests that the stock appears